BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20090379)

  • 1. Homocysteine and cognitive function in geriatric depression.
    Alexopoulos P; Topalidis S; Irmisch G; Prehn K; Jung SU; Poppe K; Sebb H; Perneczky R; Kurz A; Bleich S; Herpertz SC
    Neuropsychobiology; 2010; 61(2):97-104. PubMed ID: 20090379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine: a marker for cognitive performance? A longitudinal follow-up study.
    Teunissen CE; Blom AH; Van Boxtel MP; Bosma H; de Bruijn C; Jolles J; Wauters BA; Steinbusch HW; de Vente J
    J Nutr Health Aging; 2003; 7(3):153-9. PubMed ID: 12766792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine and cognitive impairment. Relation with diagnosis and neuropsychological performance.
    Sala I; Belén Sánchez-Saudinós M; Molina-Porcel L; Lázaro E; Gich I; Clarimón J; Blanco-Vaca F; Blesa R; Gómez-Isla T; Lleó A
    Dement Geriatr Cogn Disord; 2008; 26(6):506-12. PubMed ID: 19023204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum markers in relation to cognitive functioning in an aging population: results of the Maastricht Aging Study (MAAS)].
    Teunissen CE; van Boxtel MP; Bosma H; Jolles J; Lütjohann D; von Bergmann K; Wauters A; Bosmans E; Maes M; Delanghe J; De Bruijn C; Steinbusch HW; Blom HJ; de Vente J
    Tijdschr Gerontol Geriatr; 2003 Feb; 34(1):6-12. PubMed ID: 12629905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed.
    Sheline YI; Barch DM; Garcia K; Gersing K; Pieper C; Welsh-Bohmer K; Steffens DC; Doraiswamy PM
    Biol Psychiatry; 2006 Jul; 60(1):58-65. PubMed ID: 16414031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations.
    O'Suilleabhain PE; Sung V; Hernandez C; Lacritz L; Dewey RB; Bottiglieri T; Diaz-Arrastia R
    Arch Neurol; 2004 Jun; 61(6):865-8. PubMed ID: 15210523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life.
    Almeida OP; Flicker L; Lautenschlager NT; Leedman P; Vasikaran S; van Bockxmeer FM
    Neurobiol Aging; 2005 Feb; 26(2):251-7. PubMed ID: 15582752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired financial capacity in late life depression is associated with cognitive performance on measures of executive functioning and attention.
    Mackin RS; Areán PA
    J Int Neuropsychol Soc; 2009 Sep; 15(5):793-8. PubMed ID: 19635176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation.
    Reppermund S; Zihl J; Lucae S; Horstmann S; Kloiber S; Holsboer F; Ising M
    Biol Psychiatry; 2007 Sep; 62(5):400-6. PubMed ID: 17188252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging.
    Kado DM; Karlamangla AS; Huang MH; Troen A; Rowe JW; Selhub J; Seeman TE
    Am J Med; 2005 Feb; 118(2):161-7. PubMed ID: 15694902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in late-onset depression. Limited to a decrement in information processing resources?
    Delaloye C; Baudois S; de Bilbao F; Dubois Remund C; Hofer F; Lamon M; Ragno Paquier C; Weber K; Herrmann FR; Giardini U; Giannakopoulos P
    Eur Neurol; 2008; 60(3):149-54. PubMed ID: 18628634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging.
    Michaud K; Forget H; Cohen H
    Brain Cogn; 2009 Oct; 71(1):1-8. PubMed ID: 19428166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gender differences in the neurocognitive components of depression].
    Sárosi A; Gonda X; Balogh G; Székely A; Sasvári M; Faludi G
    Neuropsychopharmacol Hung; 2008 Oct; 10(4):191-9. PubMed ID: 19213198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
    Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E
    Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications.
    Hassin-Baer S; Cohen O; Vakil E; Sela BA; Nitsan Z; Schwartz R; Chapman J; Tanne D
    Clin Neuropharmacol; 2006; 29(6):305-11. PubMed ID: 17095893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
    Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
    Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in Behçet's disease patients without overt neurological involvement.
    Monastero R; Camarda C; Pipia C; Lopez G; Camarda LK; Baiamonte V; Ferrante A; Triolo G; Camarda R
    J Neurol Sci; 2004 May; 220(1-2):99-104. PubMed ID: 15140614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine level and cognitive function in patients with arterial disease: the second manifestations of ARTerial Disease Study.
    van Raamt AF; Kalmijn S; Mali WP; van Zandvoort MJ; van der Graaf Y;
    J Am Geriatr Soc; 2006 Apr; 54(4):575-9. PubMed ID: 16686865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.